Rectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized mice.
Rectal microbicides are being developed to prevent new HIV infections in both men and women. We focused our in vivo preclinical efficacy study on rectally-applied tenofovir. BLT humanized mice (n = 43) were rectally inoculated with either the primary isolate HIV-1JRCSF or the MSM-derived transmitted...
Guardado en:
Autores principales: | Morgan L Chateau, Paul W Denton, Michael D Swanson, Ian McGowan, J Victor Garcia |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b1364e26956e4079bcbab15ec303fc50 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice.
por: Angela Wahl, et al.
Publicado: (2012) -
Can a topical microbicide prevent rectal HIV transmission?
por: Florian Hladik, et al.
Publicado: (2008) -
A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer
por: Neeti Ananthaswamy, et al.
Publicado: (2019) -
Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
por: Mark B. Stoddard, et al.
Publicado: (2015) -
Berberine Alleviates Insulin Resistance and Inflammation via Inhibiting the LTB4–BLT1 Axis
por: Minmin Gong, et al.
Publicado: (2021)